ANTIGEN PRESENTATION BY MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-B MOLECULES

被引:223
|
作者
SHAWAR, SM [1 ]
VYAS, JM [1 ]
RODGERS, JR [1 ]
RICH, RR [1 ]
机构
[1] BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030
关键词
CYTOTOXIC T LYMPHOCYTES; H-2M3; MHC EVOLUTION;
D O I
10.1146/annurev.immunol.12.1.839
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Class I-b genes constitute the majority of MHC class I loci. These monomorphic or oligomorphic molecules have been described in many organisms; they are best characterized in the mouse, which contains a substantial number of potentially intact genes. Two main characteristics differentiate class I-b from class I-a molecules: limited polymorphism and lower cell surface expression. These distinguishing features suggest possible generalizations regarding the evolution and function of this class. Additionally, class I-b proteins tend to have shorter cytoplasmic domains or in some cases may be secreted or may substitute a lipid anchor for the transmembrane domain. Some are also expressed in a limited distribution of cells or tissues.
引用
收藏
页码:839 / 880
页数:42
相关论文
共 50 条
  • [31] 'Empty' L(d) molecules capture peptides from endocytosed hepatitis B surface antigen particles for major histocompatibility complex Class I restricted presentation
    Schirmbeck, R
    Reimann, J
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (12) : 2812 - 2822
  • [32] Thiol oxidation and reduction in major histocompatibility complex class I-restricted antigen processing and presentation
    Dick, TP
    Cresswell, P
    [J]. PROTEIN SENSORS AND REACTIVE OXYGEN SPECIES, PT B, THIOL ENZYMES AND PROTEINS, 2002, 348 : 49 - 54
  • [33] EFFICIENT MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I PRESENTATION OF EXOGENOUS ANTIGEN UPON PHAGOCYTOSIS BY MACROPHAGES
    KOVACSOVICSBANKOWSKI, M
    CLARK, K
    BENACERRAF, B
    ROCK, KL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) : 4942 - 4946
  • [34] Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus
    Hengel, H
    Reusch, U
    Geginat, G
    Holtappels, R
    Ruppert, T
    Hellebrand, E
    Koszinowski, UH
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (17) : 7861 - 7868
  • [35] Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin
    Lee, RS
    Tartour, E
    van der Bruggen, P
    Vantomme, V
    Joyeux, I
    Goud, B
    Fridman, WH
    Johannes, L
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (09) : 2726 - 2737
  • [36] Recurrent bladder cancer in aging societies: Importance of major histocompatibility complex class I antigen presentation
    Wieczorek, Edyta
    Garstka, Malgorzata A.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (08) : 1808 - 1820
  • [37] A Novel Mode of Peptide Presentation of Major Histocompatibility Complex Class I
    Li, Xiaolong
    Lamothe, Pedro
    Walker, Bruce
    Wang, Jia-huai
    [J]. PROTEIN SCIENCE, 2018, 27 : 64 - 64
  • [38] Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation
    Deussing, J
    Roth, W
    Saftig, P
    Peters, C
    Ploegh, HL
    Villadangos, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) : 4516 - 4521
  • [39] Phagocytic processing of antigens for presentation by class II major histocompatibility complex molecules
    Ramachandra, L
    Noss, E
    Boom, WH
    Harding, CV
    [J]. CELLULAR MICROBIOLOGY, 1999, 1 (03) : 205 - 214
  • [40] Major histocompatibility complex class II antigen presentation in Hodgkin's disease
    Bosshart, H
    [J]. LEUKEMIA & LYMPHOMA, 1999, 36 (1-2) : 9 - +